David E. MacCallum

1.3k total citations
21 papers, 1.1k citations indexed

About

David E. MacCallum is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David E. MacCallum has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David E. MacCallum's work include Cancer-related Molecular Pathways (12 papers), Advanced Breast Cancer Therapies (6 papers) and RNA modifications and cancer (3 papers). David E. MacCallum is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Advanced Breast Cancer Therapies (6 papers) and RNA modifications and cancer (3 papers). David E. MacCallum collaborates with scholars based in United Kingdom, Switzerland and United States. David E. MacCallum's co-authors include Peter A. Hall, David P. Lane, Athos Gianella-Borradori, Jean Melville, Sian Anderson, Sheelagh Frame, Simon R. Green, Ana Losada, Ryûji Kobayashi and Tatsuya Hirano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

David E. MacCallum

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. MacCallum United Kingdom 11 739 472 181 102 96 21 1.1k
Nancy Wainman Canada 18 686 0.9× 296 0.6× 166 0.9× 139 1.4× 149 1.6× 26 944
Barbara C. Böck Germany 13 645 0.9× 341 0.7× 135 0.7× 71 0.7× 65 0.7× 19 1.0k
Pascal Peschard Canada 16 989 1.3× 366 0.8× 258 1.4× 186 1.8× 48 0.5× 16 1.4k
Natalie von der Lehr Sweden 7 984 1.3× 557 1.2× 141 0.8× 54 0.5× 56 0.6× 8 1.2k
Hong-Ji Xu United States 15 569 0.8× 401 0.8× 60 0.3× 81 0.8× 65 0.7× 19 966
Thibault Voeltzel France 16 898 1.2× 546 1.2× 91 0.5× 111 1.1× 116 1.2× 27 1.3k
Aidan G. Gilmartin United States 12 902 1.2× 544 1.2× 244 1.3× 110 1.1× 68 0.7× 28 1.2k
Yan Degenhardt United States 16 1.1k 1.5× 663 1.4× 362 2.0× 190 1.9× 69 0.7× 23 1.6k
Robert McKinstry United States 13 475 0.6× 435 0.9× 64 0.4× 85 0.8× 105 1.1× 21 971
Gaynor Davies United Kingdom 19 576 0.8× 351 0.7× 107 0.6× 99 1.0× 44 0.5× 22 1.0k

Countries citing papers authored by David E. MacCallum

Since Specialization
Citations

This map shows the geographic impact of David E. MacCallum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. MacCallum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. MacCallum more than expected).

Fields of papers citing papers by David E. MacCallum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. MacCallum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. MacCallum. The network helps show where David E. MacCallum may publish in the future.

Co-authorship network of co-authors of David E. MacCallum

This figure shows the co-authorship network connecting the top 25 collaborators of David E. MacCallum. A scholar is included among the top collaborators of David E. MacCallum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. MacCallum. David E. MacCallum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Green, Simon, Sheelagh Frame, Sian Anderson, et al.. (2009). Abstract #3863: Derivatives of seliciclib with improved potency both in vitro and in vivo as novel cyclin dependent kinase (CDK) inhibitors. Cancer Research. 69. 3863–3863. 1 indexed citations
2.
Mistry, Hitesh, David E. MacCallum, Robert Jackson, Mark A. J. Chaplain, & Fordyce A. Davidson. (2008). Modeling the temporal evolution of the spindle assembly checkpoint and role of Aurora B kinase. Proceedings of the National Academy of Sciences. 105(51). 20215–20220. 37 indexed citations
3.
MacCallum, David E., Jean Melville, Wayne Jackson, et al.. (2006). Novel cyclin dependent kinase (CDK) inhibitors induce down regulation of Mcl-1 and apoptosis in multiple myeloma cells. Cancer Research. 66. 488–489. 1 indexed citations
4.
Bertoni, Francesco, Andrea Rinaldi, Sara Vignati, et al.. (2006). Cyclin-Dependent Kinase Inhibitor Seliciclib Shows In Vitro Activity in Diffuse Large B Cell Lymphomas.. Blood. 108(11). 4738–4738. 1 indexed citations
5.
Valentini, Alessandra, Chiara Lambertini, Monica Taborelli, et al.. (2005). In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas. Annals of Oncology. 16(7). 1169–1176. 53 indexed citations
6.
MacCallum, David E., Jean Melville, Sheelagh Frame, et al.. (2005). Seliciclib (CYC202, R-Roscovitine) Induces Cell Death in Multiple Myeloma Cells by Inhibition of RNA Polymerase II–Dependent Transcription and Down-regulation of Mcl-1. Cancer Research. 65(12). 5399–5407. 245 indexed citations
7.
8.
MacCallum, David E., Jean Melville, Sian Anderson, et al.. (2004). CYC202 (R-Roscovitine) induces apoptosis in multiple myeloma cells by down regulation of Mcl-1. Cancer Research. 64. 189–190. 4 indexed citations
9.
MacCallum, David E., Ian N. Fleming, Jean Melville, et al.. (2004). 422 The mode of action of CYC202 (R-roscovitine) a cyclin dependent kinase inhibitor currently in phase II clinical trials. European Journal of Cancer Supplements. 2(8). 126–126. 1 indexed citations
10.
Watt, Kevin, S. Anderson, Ian N. Fleming, et al.. (2004). 432 Identification of clinically relevant pharmacodynamic biomarkers in patients treated with the CDK inhibitor CYC202 (R-roscovitine). European Journal of Cancer Supplements. 2(8). 129–129. 3 indexed citations
11.
MacCallum, David E. & Ted R. Hupp. (2003). Induction of p53 Protein as a Marker for Ionizing Radiation Exposure In Vivo. Humana Press eBooks. 113. 583–589. 1 indexed citations
12.
MacCallum, David E., Ana Losada, Ryûji Kobayashi, & Tatsuya Hirano. (2002). ISWI Remodeling Complexes inXenopusEgg Extracts: Identification as Major Chromosomal Components that Are Regulated by INCENP-aurora B. Molecular Biology of the Cell. 13(1). 25–39. 115 indexed citations
13.
MacCallum, David E., Peter A. Hall, & Eric G. Wright. (2001). The Trp53 Pathway Is InducedIn Vivoby Low Doses of Gamma Radiation. Radiation Research. 156(3). 324–327. 18 indexed citations
14.
MacCallum, David E. & Peter A. Hall. (2000). The biochemical characterization of the DNA binding activity of pKi67. The Journal of Pathology. 191(3). 286–298. 49 indexed citations
15.
MacCallum, David E. & Peter A. Hall. (2000). The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. The Journal of Pathology. 190(5). 537–544. 96 indexed citations
16.
MacCallum, David E. & Peter A. Hall. (2000). The biochemical characterization of the DNA binding activity of pKi67. The Journal of Pathology. 191(3). 286–298. 2 indexed citations
17.
MacCallum, David E. & Peter A. Hall. (2000). The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. The Journal of Pathology. 190(5). 537–544. 6 indexed citations
18.
MacCallum, David E. & Peter A. Hall. (1999). Biochemical Characterization of pKi67 with the Identification of a Mitotic-Specific Form Associated with Hyperphosphorylation and Altered DNA Binding. Experimental Cell Research. 252(1). 186–198. 56 indexed citations
19.
MacCallum, David E., et al.. (1998). Expression of the ‘DEAD box’ RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus. The Journal of Pathology. 184(4). 351–359. 95 indexed citations
20.
Bub, Jeffrey & David E. MacCallum. (1988). Book review. Foundations of Physics Letters. 1(4). 395–399. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy Wainman Breakdown of academic impact, for papers by Barbara C. Böck Breakdown of academic impact, for papers by Pascal Peschard Breakdown of academic impact, for papers by Natalie von der Lehr Breakdown of academic impact, for papers by Hong-Ji Xu Breakdown of academic impact, for papers by Thibault Voeltzel Breakdown of academic impact, for papers by Aidan G. Gilmartin Breakdown of academic impact, for papers by Yan Degenhardt Breakdown of academic impact, for papers by Robert McKinstry Breakdown of academic impact, for papers by Gaynor Davies
Rankless by CCL
2026